Soy isoflavones attenuate ovariectomy-induced bone loss in stroke-prone spontaneously hypertensive rats (SHRSP)

Journal of Clinical Biochemistry and Nutrition

Volumn 28, Issue 1, 2000, Pages 15-20

  Teramoto, Takanori ^a,b   Fukui, Yutaka ^a,b   Ikeda, Katsumi ^a   Yamori, Yukio ^a  

^a KYOTO UNIVERSITY   (Japan)

^b WHO Collaborating Center for Research on Primary Prevention of Cardiovascular Diseases   (Japan)

Author keywords

Bone density; Bone loss; Bone resorption marker; SHRSP; Soy isoflavone

Indexed keywords

DAIDZIN; DEOXYPYRIDINOLINE; GENISTIN; ISOFLAVONE DERIVATIVE; PYRIDINOLINE;

ANIMAL EXPERIMENT; ARTICLE; BONE DENSITY; BONE MASS; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; FEMUR; FRACTURE; HYPERTENSION; NONHUMAN; OSTEOLYSIS; OVARIECTOMY; RAT; RISK FACTOR; SOYBEAN; STROKE;

ANIMALIA; GLYCINE MAX;

EID: 0034590828     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.28.15     Document Type: Article

References (20)

1. Albright, F., Smith, P.H., and Richardson, A.M. (1941): Postmenopausal osteoporosis: Its clinical features. J. Am. Med. Assoc., 116, 2465-2474.
2. Kao, P.C., and P'eng, F.K. (1995): How to reduce the risk factors of osteoporosis in Asia. Chin. Med. J., 55, 209-213.
3. Ho, S.C., Bacon, W.E., Harris, T., Looker, A., and Maggi, S. (1993): Hip fracture rates in Hong Kong and the United States, 1988 through 1989. Am. J. Public Health, 83, 694-697.
4. Adlercreutz, H., and Mazur, W. (1997): Phyto-oestrogens and Western diseases. Ann. Med., 29, 95-120.
5. Coward, L., Barnes, N.C., Setchell, K.D.R., and Barnes, S. (1993): The antitumor isoflavones, genistein and daidzein, in soybean foods of American and Asian diets. J. Agric. Food Chem., 41, 1961-1967.
6. Yamori, Y., Fukuda, T., Tsuchikura, K., Ikeda, K., Nara, Y., and Horie, R. (1991): Stroke-prone SHR (SHRSP) as a model for osteoporosis. Clin. Exp. Hypertens. A, 13, 755-762.
7. Kalu, D.N., Liu, C.C., Salerno, E., Hollis, B.W., Echon, R., and Ray, M. (1991): Skeletal response of ovariectomized rats to low and high doses of 17β-estradiol. Bone Miner., 14, 175-187.
8. Takahashi, M., Ohishi, T., Aoshima, H., Kushida, K., Inoue, T., and Horiuchi, K. (1993): Prefractionation with cation exchanger for determination of intermolecular crosslinks, pyridinoline and pentosidine, in hydrolysate. J. Liq. Chromatogr., 16, 1355-1370.
9. Kent, G.N. (1995): Markers of bone resorption and their application in metabolic bone disease. Clin. Biochem. Rev., 16, 4-10.
10. Goulding, A., Gold, E., and Lewis, B.N.J. (1996): Effects of hysterectomy on bone in intact rats, ovariectomized rats, and ovariectomized rats treated with estrogen. J. Bone Miner. Res., 11, 977-983.
11. Prestwood, K.M., Pilbeam, C.C., Burleson, J.A., Woodiel, F.N., Delmas, P.D., Deftos, L.J., and Raisz, L.G. (1994): The short-term effects of conjugated estrogen on bone turnover in older women. J. Clin. Endocrinol. Metab., 79, 366-371.
12. Chen, J.T., Hosoda, K., Hasumi, K., Ogata, E., and Shiraki, M. (1996): Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal women. J. Bone Miner. Res., 11, 1784-1792.
13. Murkies, A. (1998): Phytoestrogens - What is the current knowledge? Aust. Fam. Physician, 27, S47-S51.
14. Markiewicz, L., Garey, J., Adlercreutz, H., and Gurpide, E. (1993): In vitro bioassays of non-steroidal phytoestrogens. J. Steroid Biochem. Mol. Biol., 45, 399-405.
15. Miksikek, R.J. (1994): Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J. Steroid Biochem. Mol. Biol., 49, 153-160.
16. Yamaguchi, M., and Gao, Y.H. (1998): Inhibitory effect of genistein on bone resorption in tissue culture. Biochem. Pharmacol., 55, 71-76.
17. Blair, H.C., Jordan, S.E., Peterson, T.G., and Barnes, S. (1996): Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. J. Cell. Biochem., 61, 629-637.
18. Bahram, H.A., Dilshad, A.K., Shanil, S.J., and Alvar, S. (1997): The ovarian hormone deficiency-induced hypercholesterolemia is reversed by soy protein and the synthetic isoflavone, ipriflavone. Nutr. Res., 17, 885-894.
19. Roudebush, R.E., Magee, D.E., Benslay, D.N., Bendele, A.M., and Bryan, H.U. (1993): Effect of weight manipulation on bone loss due to ovariectomy and the protective effects of estrogen in the rats. Calcif. Tissue Int., 53, 61-64.
20. Shimizu, H., Shimomura, Y., Nakanishi, Y., Futawatari, T., Ohtani, K., Sato, N., and Mori, M. (1997): Estrogen increases in vivo leptin production in rats and human subjects. J. Endocrinol., 154, 285-292.